2025-2026 Regular Session • New York Legislature
S04501
Legislative Summary
Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/6/2025
REFERRED TO HIGHER EDUCATION
Senate
Status Information
Current Status
Introduced(2/6/2025)
Chamber
Senate
Committee
Higher Education(Senate)
